Chemical aspects of organotin derivatives of beta-diketones, quinonoids, steroids and some currently used drugs: A review of the literature with emphasis on the medicinal potential of organotins

Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry

Volumn 37, Issue 7, 2007, Pages 507-525

  Valla, Vasiliki ^a   Bakola Christianopoulou, Maria ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Anticancer; Aromatase inhibitors; Disruptors; Endocrine; Organometallic complexes; Organotin

Indexed keywords

EID: 34648831441     PISSN: 15533174     EISSN: 15533182     Source Type: Journal    
DOI: 10.1080/15533170701558087     Document Type: Article

References (112)

1. Yasuda, M.; Chiba, K.; Baba, A. An ab initio computational study on the reaction of organotin enolates: comparison of highly coordinated tin reagent with non-coordinated reagent. J. Am. Chem. Soc. 2000, 122, 7549-7555.
2. Blunden, S. J.; Hill, R.; Sutton, S. E. A thermal analytical study of some mono- and di-organotin oxides and carboxylates. Appl. Organometal. Chem. 1991, 5, 159-165.
3. Pellerito, L.; Nagy, L. Organotin(IV)n+ complexes formed with biologically active ligands: Equilibrium and structural studies, and some biological aspects. Coord. Chem. Rev. 2002, 224, 111-150.
4. Price, J. Tin in the world of today's price. Fresenius Z. Anal. Chem. 1977, 288, 257-261.
5. Hoch, M. Organotin compounds in the environment-an overview. Appl. Geochem. 2001, 16 (7-8), 719-743.
6. Konstantinou, I. K.; Albanis, T. A. Worldwide occurrence and effects of antifouling paint booster biocides in the aquatic environment: a review. Environ. Int. 2004, 30 (2), 235-248.
7. Rudel, H. Case study: bioavailability of tin and tin compounds. Ecotoxicol. Environ. Saf. 2003, 56 (1), 180-189.
8. Fent, K. Ecotoxicological problems associated with contaminated sites. Toxicol. Lett. 2003, 140-141, 353-365.
9. Champ, U. A review of organotin regulatory strategies, pending actions, related costs and benefits. Sci. Total Environ. 2000, 258, 21-71.
10. Valla, V.; Christianopoulou, M.; Akrivos, P.; Kojic, V.; Bogdanovic, G. Synthesis, structure and in-vitro cytotoxicity of new hydroxy-naphthoquinonato triorganotin compounds. Syn. React. Inorg. Met. 2006, 36 (10), 765-775.
11. Valla, V.; Kojic, V.; Bogdanovic, G.; Christianopoulou, M. Synthesis, spectroscopy and in-vitro cytotoxicity of new hydroxyanthraquinonato triorganotin compounds. Syn. React. Inorg. Met. 2007, 37 (1), 41-45.
12. Chandrasekhar, V.; Nagendran, S.; Baskar, V. Organotin assemblies containing Sn-O bonds. Coord. Chew. Rev. 2002, 235, 1-52.
13. Chandrasekhar, V.; Gopal, K.; Sasikumar, P.; Thirumoorthi, R. Organooxotin assemblies from Sn-C bond cleavage reactions. Coord. Chem. Rev. 2005, 249, 1745-1765.
14. Gielen, M.; Lelieveldb, P.; de Vos, D.; Pan, H.; Willem, R.; Bieseman, M.; Fiebigf, H. In vitro effect of organotin-substituted steroids in human tumor cell lines. Inorg. Chim. Acta. 1992, 196, 115-117.
15. Gielen, M. Tin-based antitumour drugs. Coord. Chem. Rev 1996, 151, 41-51.
16. Gielen, M.; Biesemans, M.; de Vos, D.; Willem, R. Synthesis, characterization and in vitro antitumor activity of di- and triorganotin derivatives of polyoxa and biologically relevant carboxylic acids. J. Inorg. Biochem 2000, 79, 139-145.
17. Gielen, M. Organotin compounds and their therapeutic potential: A report from, the Organometaliic Chemistry Department of the free University of Brussels. Appl. Organometal. Chem. 2002, 16, 481-494.
18. Gielen, M. An overview of forty years organotin chemistry developed at the Free Universities of Brussels ULB and VUB. J. Braz. Chem. Soc. 2003, 14 (6), 870-877.
19. Gielen, M.; Biesemans, M.; Willem, R. Organotin compounds: from kinetics to stereochemistry and antitumour activities. Appl. Organometal. Chem. 2005, 19, 440-450.
20. Tiekink, E. R. T. Structural chemistry of organotin carboxylates: A review of the crystallographic literature. Appl. Organometal. Chem. 1991, 5, 1-23.
21. Szorcsik, A.; Nagy, L.; Pellerito, L.; Yamaguchi, T.; Yoshida, K. Preparation and structural studies of organotin(IV) complexes formed with organic carboxylic acids. J. Radioanal. Nucl. Chem. 2003, 256(1), 3-10.
22. Szorcsik, A.; Nagy, L.; Gyurcsik, B.; Vankó, G.; Krämer, R.; Vértes, A.; Yamaguchi, T.; Yoshida, K. Organotin (IV) complexes of polyhydroxyalkyl carboxylic acids and some related ligands. J. Radioanal. Nucl. Chem. 2004, 260 (3), 459-469.
23. Szorcsik, A.; Nagy, L.; Scopelliti, M.; Deak, A.; Pellerito, L.; Hegetschweiler, K. Preparation and structural characterization of organotin(IV) complexes with ligands containing a hetero {N} atom and a hydroxy group or hydroxy and carboxyl groups. J. Organometal. Chem. 2005, 690, 2243-2253.
24. Pettinari, C.; Marchetti, F.; Cingolani, A.; Leonesi, D.; Lobbia, G.; Lorenzotti, A. Tin(IV) and organotin(IV) complexes with heterocyclic β-diketonates. I. Bis-[4(1-phenyl-3-methyl-pyrazol-5-one)]-dioxoalkane derivatives. J. Organometal. Chem. 1993, 454, 59-66.
25. Bovio, B. Tin(IV) and organotin(IV) complexes containing the anion of some substituted-3-methyl-4-a&5-pyrazdlones. Crystal structure of dimethylbis(1-phenyl-3-methyl-4-benzoyl pyrazolon5ato) tin(IV). J. Organometal. Chem. 1993, 458, 39-48.
26. Pettinari, C.; Marchetti, F.; Leonesi, D.; Rossi, M.; Caruso, F. Synthesis, characterization and spectroscopic investigations of tin(IV) and organotin(IV) derivatives of 4-aroyl-S-pyrazolones. Crystal structure of trans-dimethylbis[1-phenyl-3-methyl- 4-(4-bromobenzoyl)-pyrazolon-5-ato]tin(IV). J. Organometal. Chem. 1994, 483, 123-137.
27. Mahon, M. F.; Molloy, K. C.; Omotowa, B. A.; Mesubi, M. A. Organotin(IV) derivatives of acylpyrazol-5-ones. J. Organometal. Chem. 1996, 511, 227-237.
28. Marchetti, F.; Pettinari, C.; Cingolani, A.; Gioia Lobbia, G.; Cassetta, A.; Luisa Barba, L. Triorganotin(IV) derivatives of several 4-acyl-5- pyrazolonato ligands: synthesis, spectroscopic characterization and behavior in solution. Crystal structure of aquotrimethyl(4-p-methoxybenzoyl-1-phenyl-3- methyl-pyrazolon-5-ato)tin(IV). J. Organometal. Chem. 1996, 517, 141-154.
29. 119Sn NMR) and behavior in solution. Crystal, and molecular structure of trans-diphenyl bis[1-phenyl-3-methyl-44 4-bromo-benzoyl)-pyrazolon-5-ato]tin(IV). J. Organometal. Chem. 1996, 519, 29-44.
30. Pettinari, C.; Caruso, F.; Zaffaroni, N.; Villa, R.; Marchetti, F.; Pettinari, R.; Phillips, C.; Tanski, J.; Rossi, M. Synthesis, spectroscopy (IR, multinuclear NMR, ESI-MS), difraction, density functional study and in vitro antiproliferative activity of pyrazole-beta-diketone dihalotin(IV) compounds on 5 melanoma cell lines. J. Inorg. Biochem. 2006, 100, 58-69.
31. Marchetti, F.; Pettinari, C.; Pettinari, R. Acylpyrazolone ligands: Synthesis, structures, metal coordination chemistry and applications. Coord, Chem. Rev. 2005, 249, 2909-2945.
32. Jain, A.; Saxena, S.; Rai, A.; Saxena, P. Assessment of toxicity of some penta and hexacoordinated organotin(IV) and tetracoordinated tin(II) complexes of heterocyclic β-diketones. Bioinorg. Chem. Appl. 2006, 601 (40), 1-4.
33. 7). Crystal and molecular structure of trans-dimethylbis [1-phenyl-3-methyl-4-i-propoxycarbonyl-pyrazolon- 5-ato]tin(IV). Inorg. Chim, Acta. 1997, 257, 37-48.
34. 2. Inorg. Chim. Acta. 1997, 262, 33-46.
35. Pettinari, C.; Marchetti, F.; Cingolani, A.; Leonesi, D.; Mundorff, E.; Rossi, M.; Caruso, F. Tin(IV) and organotin(IV) derivatives of novel b-diketones. III1 Diorgano- and dihalotin(IV) complexes of 1,3-dimethyl-4-R(C_O) -pyrazol-5-one (R_CH3, C6H5) and the crystal structure of trans- dicyclohexylbis(1,3-dimethyl-4-acetylpyrazolon-5-ato)tin(IV). J. Organometal. Chem. 1998, 557, 187-205.
36. Nieto-Alvarez, D. A.; Jimenez-Cruz, F.; Mancilla, T. Synthesis and characterization of new di-n-butylhydroxytin(IV) derived compounds from 1,3-diketone malonates. Polyhedron 2002, 21, 417-420.
37. Nieto-Alvarez, D. A.; Jimenez-Cruz, F.; Mancilla, T. Synthesis and characterization of new di-n-butyl. [bis{dimethyl-2-(3-oxo5-phenyl(4-subtituted) -penten-5-ato)malonates}]tin(IV): The crystal, structure of di-n- butyl[bis{dimethyl-2-[5-(4-nitrophenyr)-3-oxo-penten-5-ato]malonate}]tin (IV). Polyhedron 2005, 24, 1054-1062.
38. Brown, M.; McGarvey, B.; Ozarowski, A.; Tuck, D. Studies of organotin (IV)-otthoquinone systems. J. Organometal., Chem. 1998, 550, 165-172.
39. Shahzadi, S.; Shahid, K.; Ali, S.; Mazhar, M.; Badshah, A.; Ahmed, E.; Malik, A. Non-steroidal anti-inflammatory drugs (NSAIDs) as donor ligands in organotin(IV) derivatives: synthesis, spectroscopic characterization and biological applications. Turk. J. Chem. 2005, 29, 273-287.
40. Tian, L.; Yu, Q.; Zheng, X.; Shang, Z.; Liu, X.; Qian, B. Synthesis, characterization and in vitro antitumour activity of di-and tri-organotin derivatives of fenbufen. Appl. Organometal. Chem. 2005, 19, 672-676.
41. Kovala-Demertzi, D. Recent advances on non-steroidal anti-inflammatory drugs, NSAIDs: Organotin complexes of NSAIDs. J. Organometal, Chem. 2006, 691 (8), 1767-1774.
42. Galani, A.; Demertzis, M. A.; Kubicki, M.; Kovala-Demertzi, D. Organotin-drug interactions, organotin adducts of lornoxicam, synthesis and characterisation of the first complexes of Lornoxicam. Eur. J. Inorg. Chem. 2003, 9 (1), 1761-1767.
43. Demertzis, M. A.; Hadjikakou, S. K.; Kovala-Demerzi, D.; Koutsodimou, A.; Kubicki, M. Organotin-drug interactions. organotin adducts of tenoxicam: synthesis and characterization of the first organotin complex of Tenoxicam. Helv. Chim. Acta 2003, 83, 2787-2801.
44. Maggio, F.; Pellerito, A.; Pellerito, L.; Grimaudo, S.; Mansueto, C; Vitturi, R. Organometallic complexes with biological, molecules II. Synthesis, solid-state characterization and in vivo cytotoxicity of diorganotin(1V)chloro and triorganotin(1V)chloro derivatives of penicillin G. Appl. Organometal. Chem. 1994, 8, 71-85.
45. 2 in aqueous solution, and biological aspects of some dialkyltin(IV) derivatives of this ligand. J Organometal. Chem. 2003, 668, 129-139.
46. Singh, H. L.; Gupta, M. K.; Varshney, A. K. Organotin(IV) complexes of Schiff bases derived by condensation of heterocyclic ketones and sulfa drugs. Res. Chem. Intermed. 2001, 27 (6), 605-614.
47. Saxena, A.; Huber, F.; Pellerito, L.; Girasolot, A. Organo-element derivatives of steroids: Synthesis and structural features of organo-silicon, -tin and -lead derivatives of cholesterol and desoxycholic acid. Appl. Organometal. Chem. 1987, 1, 413-421.
48. Saxena, A. K. Organotin compounds: toxicology and biomedicinal applications. Appl. Organometal. Chem. 1987, 1, 39-56.
49. Buchanan, H. J.; Cox, P.; Wardell, J. L. Synthesis and structure determination of 3a-triphenylstannyl-cholest-5-ene. J. Chem. Crystal. 1996, 26 (3), 219-222.
50. Sherman, L.; Soma, D.; Thoman, C. The acute toxicity of tri-nbutyltin taurocholate. Appl. Organometal. Chem. 1987, 1, 359-362.
51. Sherman, L.; Koch, J. R.; Thornant, C.; Zimmermans, M. R. The acute toxicity of tri-n-butyltin glycocholate. Appl. Organometal, Chem. 1988, 2,451-455.
52. Schafer, S. G.; Femfert, U. Tin-A toxic heavy metal? A review of the literature. Reg. Toxicol. Pharmacol. 1984, 4, 57-69.
53. Appel, K. E. Organotin compounds: toxicokinetic aspects. Drug Metab Rev 2004, 36 (3-4), 763-786.
54. Tsangaris, J. M.; Williamst, D. R. Tin in pharmacy and nutrition. Appl. Organometal. Chem. 1992, 6, 3-18.
55. Nicklin, S.; Robson, M. W. Organotins: toxicology and biological effects. Appl. Organometal. Chem 1988, 2, 487-508.
56. Ueno, S.; Kashimoto, T.; Susa, N.; Ishii, M.; Chiba, T.; Mutoh, K.; Hoshi, F.; Suzuki, T.; Sugiyama, M. Comparison of hepatotoxicity and metabolism of butyltin compounds in the liver of mice, rats and guinea pigs. Arch. Toxicol. 2003, 77, 173-181.
57. Musmeci, M. T.; Madonia, G.; Lo Giudice, M. T.; Silvestri, A.; Ruisi, G.; Barbieri, R. Interactions of organotins with biological systems. Appl. Organometal. Chem. 1992, 6, 127-138.
58. Gomez, F. D.; Apodaca, P.; Holloway, L. N.; Pannell, K. H.; Whalen, M. Effect of a series of triorganotins on the immune function of human natural killer cells. Environm. Toxicol. Pharmacol. 2007, 23 (1), 18-24.
59. Ohhira, S.; Watanabe, M.; Matsui, H. Metabolism of tributyltin and triphenyltin by rat, hamster and human hepatic microsomes. Arch. Toxicol. 2003, 77, 138-144.
60. Snoeij, N. J.; Penninks, A. H.; Seinen, W. Biological activity of organotin compounds-An overview. Environ. Res. 1987, 44, 335-353.
61. Inadera, H. The immune system as a target for environmental chemicals: Xenoestrogens and other compounds. Toxicol. Lett. 2006, 164(3), 191-206.
62. Rotchell, J. M.; Ostrander, G. K. Molecular markers of endocrine disruption in aquatic organisms. J. Toxicol. Environ. Health. Pt. B 2003, 6, 453-495.
63. Ohhira, S.; Enomoto, M.; Matsui, H. In vitro metabolism of tributyltin and triphenyltin by human cytochrome P-450 isoforms. Toxicology 2006, 228, 171-177.
64. Rémi Thibaut, R.; Cinta Porte, C. Effects of endocrine disrupters on sex steroid synthesis and metabolism pathways in fish. J. Steroid Biochem. Mol. Biol. 2004, 92 (5), 485-494.
65. Sanderson, T.; van den Berg, M. Interactions of xenobiotics with the steroid hormone biosynthesis pathway. Pure Appl. Chem. 2003, 75 (11-12), 1957-1971,
66. Grote, K.; Andrade, A.; Grande, S. W.; Kuriyama, S. N.; Talsness, C. E.; Appel, K. E.; Chahoud, I. Effects of peripubertal exposure to triphenyltin on female sexual development of the rat. Toxicology 2006, 222 (1-2), 17-24.
67. Nakanishi, T.; Kohroki, J.; Suzuki, S.; Ishizaki, J.; Hiromori, Y.; Takasuga, S.; Itoh, N.; Watanabe, Y.; Utoguchi, N.; Tanaka, K. Trialkyltin compounds enhance human CG secretion and aromatase activity in human placental choriocarcinoma cells. J. Clin. Endocrinol. Metab. 2002, 87 (6), 2830-2837.
68. Saitoh, M.; Yanase, T.; Morinaga, H.; Tanabe, M.; Mu, Y.-M.; Nishi, Y.; Nomura, M.; Okabe, T.; Goto, K.; Takayanagi, R.; Nawata, H. Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell, line KGN. Biochem. Biophys. Res. Comm. 2001, 289, 198-204.
69. Cooke, G. M. Effect of organotins on human aromatase activity in vitro. Toxicol. Lett. 2002, 126, 121-130.
70. Hinfray, N.; Porcher, J. M.; Brion, F. Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances. Compar. Biochem. Physiol. Pt. C 2006, 144 (3), 252-262.
71. Heidrich, D. D.; Steckelbroeck, S.; Klingmuller, D. Inhibition of human cytochrome P450 aromatase activity by butyltins. Steroids 2001, 66, 763-769.
72. Lo, S.; Alléra, A.; Albers, P.; Heimbrecht, J.; Jantzen, E.; Klingmüller, D.; Steckelbroeck, S. Dithioerythritol (DTE) prevents inhibitory effects of triphenyltin (TPT) on the key enzymes of the human sex steroid hormone metabolism. J. Steroid Biochem Mol. Biol. 2003, 84, 569-576.
73. Doering, D. D.; Steckelbroeck, S.; Doering, T.; Klingmüller, D. Effects of butyltins on human 5-reductase type 1 and type 2 activity. Steroids 2002, 67, 859-867.
74. Ohno, S.; Nakajima, Y.; Nakajin, S. Triphenyltin and tributyltin inhibit pig testicular 17/3 hydroxysteroid dehydrogenase activity and suppress testicular testosterone biosynthesis. Steroids 2005, 70, 645-651.
75. Golub, M. S.; Doherty, J. D. Triphenyltin as a potential human endocrine disruptor. J. Toxicol. Environ. Health, Pt. B 2004, 7, 281-295.
76. Osada, S.; Nishikawaa, J.; Nakanishi, T.; Tanakab, K.; Nishiharaa, T. Some organotin compounds enhance histone acetyltransferase activity. Toxicol. Lett. 2005, 155, 329-335.
77. Nielsen, J. B.; Rasmussen, T. H. Antiproliferative effect of butyltin in MCF-7 cells. Environ. Res. 2004, 96, 305-310.
78. Ohkimoto, K.; Sakakibaraa, Y.; Suiko, M.; Yoshikawa, H.; Liu, M.; Tamuram, H. Biocides, tributyltin and triphenyltin, as possible inhibitors of the human sulfotransferase involved in the estrogen homeostasis. Pestic. Biochem. Physiol, 2005, 81, 32-38.
79. Atanasov, A.; Nashev, L. G.; Tam., S.; Baker, M. E.; Odermatt, A. Organotins disrupt the 11b-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids. Environ. Health Perspect. 2005, 113 (11), 1600-1606.
80. Kanayama, T.; Kobayashi, N.; Mamiya, S.; Nakanishi, T.; Nishikawa, J. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor γ/retinoid X receptor pathway. Mol. Pharmacol. 2005, 67 (3), 766-774.
81. Nakanishi, T.; Nishikawa, J.; Hiromori, Y.; Yokoyama, H.; Koyanagi, M.; Takasuga, S.; Ishizaki, M.; Watanabe, M.; Isa, S.; Utoguchi, N.; Itoh, N.; Kohno, Y.; Nishihara, T.; Tanaka, K. Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions. Mol. Endocrinol. 2005, 19 (10), 2502-2516.
82. Grun, F.; Blumberg, B. Environmental obesogens. Endocrinology 2006, 147 (6), 50-55.
83. Ortiz, A.; Teruel, J.; Aranda, F. J. Effect of triorganotin compounds on membrane permeability. Biochim. Biophys. Acta 2005, 17(20), 137-142.
84. Teruel, J. A.; Ortiz, A.; Aranda, F. J. Influence of organotin compounds on phosphatidylserine membranes. Appl. Organometal. Chem. 2004, 18, 111-116.
85. Nakanishi, T.; Hiromori, Y.; Yokoyama, H.; Koyanagi, M.; Itoh, N.; Nishikawa, J. I.; Tanaka, K. Organotin compounds enhance 17β-hydroxysteroid dehydrogenase type I activity in human choriocarcinoma JAr cells: Potential promotion of 17β-estradiol biosynthesis in human placenta. Biochem. Pharmacol. 2006, 71(9), 1349-1357.
86. Nakanishi, T.; Nishikawa, J.; Tanaka, K. Molecular targets of organotin compounds endocrine disruption: do organotin compounds function as aromatase inhibitors in mammals? Environ. Sci. 2006b, 13 (2), 89-100.
87. Morcillo, Y.; Porte, C. Evidence of endocrine disruption in the imposex-affected gastropod Bolinus brandaris. Environ. Res. 1999, 81, 349-354.
88. Oberdorster, E. Peptide hormones versus steroid hormones: case studies from snail and turtle populations. Ann. NY Acad. Sci. 2001, 948, 75-79.
89. Sherman, L. R.; Hubert, F. Relationship of cytotoxic groups in organotin molecules and the effectiveness of the compounds against leukemia. Appl. Organometal. Chem. 1988, 2, 65-72.
90. Tabassum, S.; Pettinari, C. Chemical and biotechnological developments in organotin cancer chemotherapy. J. Organometal. Chem. 2006, 691 (8), 1761-1766.
91. Song, X.; Zapata, A.; Eng, G. Organotins and quantitative-structure activity/property relationships. J. Organometal. Chem. 2006, 691 (8), 1756-1760.
92. Janesó, A.; Nagy, L.; Moldrheim, E.; Sletten, E. Potentiometric and spectroscopic evidence for co-ordination of dimethyltin(IV) to phosphate groups of DNA fragments and related ligands. J. Chem, Soc. Dalton Trans. 1999, 1587-1594.
93. Silvestri, A.; Ruisi, G.; Barbieri, R. The interaction of DNA with organotin(IV) salts and complexes. Hyperf. Interact. 2000, 126, 43-46.
94. Buck-Koehntop, B. A.; Porcelli, F.; Lewin, J. L.; Cramer, C. J.; Veglia, G. Biological chemistry of organotin compounds: Interactions and dealkylation by dithiols. J. Organometal. Chem. 2006, 691 (8), 1748-1755.
95. Boualam, M.; Willem, R.; Biesemans, M.; Gielen, M. Synthesis, characterization and in vitro antitumor activity of dimethyl-, diethyl, and di-t-butyl-t in (IV) derivatives of substituted salicylic acids. Appl. Organometal. Chem. 1991, 5, 497-506.
96. Gielen, M.; Willem, R.; Biesemans, M.; Boualam, M.; Khloufi, A. El.; de Vos, D. Exceptionally high in vitro antitumor activity of substituted triphenyltin benzoates including salicylates against a human mammary tumor, MCF-7, and a colon, carcinoma, WiDr. Appl. Organometal. Chem. 1992, 6 (3), 287-291.
97. Nath, M.; Jairath, R.; Eng, G.; Song, X.; Kumar, A. Interaction of triorganotin(IV) cations with pyrimidme bases/nucleoside: synthesis, spectral characterization and biological studies of a novel triphenyltin(IV) derivative of thymidine. Inorg. Chem. Comm. 2004, 7, 1161-1163.
98. Nath, M.; Jairath, R.; Eng, G.; Song, X.; Kumar, A. Synthesis, spectral characterization and biological studies of some organotin(IV) complexes of L-proline, trans-hydroxy-L-proline and L-glutamine. Spectr. Chim. Acta, pt A 2005, 62 (4-5), 1179-1187.
99. Apps, D. K.; Webster, L. C. Interaction of organotins with a vacuolar-type H/-ATPase. Biochem. Biophys. Res. 1996, 227 (3), 839-845.
100. Kishta, O.; Adeeko, A.; Li, D.; Luu, T. R.; Brawer, J.; Morales, C.; Hermo, L.; Robaire, B.; Hales, B.; Barthelemy; Cyr, D.; Trasler, J. In utero exposure to tributyltin chloride differentially alters male and female fetal gonad morphology and gene expression profiles in the Sprague-Dawley rat. Repr. Toxicol. 2007, 23 (1), 1-11.
101. Pettinari, C.; Marchetti, F.; Cingolani, A.; Phillips, C.; Tanski, J.; Rivarola, E. Tin(II) and lead(II) 4-acyl-5-pyrazolonates: Synthesis, spectroscope and x-ray structural characterization. Eur. J. Inorg. Chem 2004, 17, 3484-3497.
102. Jankovics, H.; Pettinari, C.; Marchetti, F.; Kamu, E.; Nagy, L.; Troyanov, S.; Pellerito, L. Characterization of diorganotin(IV) complexes with Captopril. The first crystallographically authenticated metal complex of this anti-hypertensive agent. J. Inorg. Biochem. 2003, 97, 370-376.
103. Marchetti, F.; Pettinari, C.; Cingolani, A.; Brocanelli, L.; Rossi, M.; Caruso, F. Tin(IV) and organotin(IV) derivatives of novel b-diketones Part IV. Triorganotin(IV) complexes of fluorinated 4-acyl-5-pyrazolones. Crystal structure of (1(4-trifluoromethylphenyl)-3-methyl-4-acetylpyrazolon-5-ato) triphenyltin(IV). J. Organometal. Chem. 1999, 580, 344-353.
104. Marchetti, F.; Pettinari, C.; Cingolani, A.; Brocanelli, L.; Rossi, M.; Caruso, F. Organotin(IV) derivatives of novel diketones Part V. Synthesis and characterization of di- and triorganotin(IV) derivatives of 4-acyl-5-pyrazolones modified in position 3 of the pyrazole. Crystal structure of (1,3-diphenyl-4-benzoylpyrazolon-5-ato)triphenyltin(IV). J. Organometal. Chem. 2002, 645, 134-145.
105. Nath, M.; Jairath, R.; Engb, G.; Songb, X.; Kumarc, A. New organotin(IV) ascorbates: synthesis, spectral characterization, biological and potentiometric studies. Spectrochim. Acta Pt. A 2005, 61, 77-86.
106. Nath, M.; Jairath, R.; Eng, G.; Song, X.; Kumar, A. New diorganotin(IV) derivatives of 7-hydroxycoumarin (umbelliferone) and their adducts with 1,10-phenanthroline. Spectrochim. Acta Pt. A 2005, 61 (13-14), 3155-3161.
107. Nath, M.; Pokharia, S.; Eng, G.; Song, X.; Kumar, A. New triorganotin(IV) derivatives of dipeptides as anti-inflammatory-anti-microbial agents. Eur. J. Med. Chem. 2005, 40 (3), 289-298.
108. Papa, S.; Guerrieri, F.; De Gommez Puyou, M.; Barranco, J.; De Gommez Puyou, A. Studies on the mechanism of action of triphenyltin on proton conduction by the H + -ATPase of mitochondria. Eur. J. Biochem. 1982, 128, 1-7.
109. Pellerito, C.; Nagy, L.; Pellerito, L.; Szorcsik, A. Biological activity studies on organotin(IV)n+ complexes and parent compounds. J. Organometal. Chem. 2006, 691 (8), 1733-1747.
110. Pettinari, C.; Rafaiani, G.; Lobbia, G.; Lorenzotti, A.; Bonati, F. Organotin derivatives of 4-acyl-S-pyrazolones. Crystal structure of trans-di(t-butyl) bis(1-phenyl-3-methyl-4-benzoyl-pyrazolon-S-ato) tin(IV). J. Organometal. Chem. 1991, 405, 75-92.
111. Bara, A.; Socaciu, C.; Silvestru, C.; Haiduc, I. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor. Anticancer Res. 1991, 11 (4), 1651-1655.
112. Billingsley, ML.; Yun, J.; Reese, BE.; Davidson, CE.; Buck-Koehntop, BA.; Veglia, G. Functional and structural properties of stannin: roles in cellular growth, selective toxicity, and mitochondrial responses to injury. J. Cell Biochem. 2006, 98 (2), 243-250.